Why Pfizer Stock Bolted Higher in July

Why Pfizer Stock Bolted Higher in July

What happened Mega-cap pharma stocks rarely surge by double digits over just a 30-day period. But that's exactly what Pfizer's (NYSE: PFE) stock accomplished during the month of July. Despite facing falling sales for a host of former blockbuster medicines and the impending spin-off of its legacy products unit, Pfizer's shares gained an astounding 17.